Generally the role of social media is to connect with others. However, patients all over the world have found a way to make those outlets even more advantageous. Patients with rare diseases are more motivated to find others with the same disease in order to facilitate...
In the wake of the recent commotion surrounding flawed research at Duke University on diagnostic tools based on molecular patterns (“omics” tests), an Institute of Medicine (IOM) panel has issued a report entitled Evolution of Translational Omics: Lessons Learned and...
Save the date Wednesday June 13, 2012 for the Eighth Annual Research Symposium by St. Vincent Health. The event will go from 7:00am-4:00pm at the Lilly Conference Center at the Marten House. The main topics will be regulatory updates, family medicine, women’s...
Several sources have recently pointed to possible links between poor patient adherence during clinical drug trials and unexpected adverse effects—as well as personal injury cases—once the drug is approved and marketed. Chief among these sources is the Consumer Health...
A report released Feb. 29th by the Institute of Medicine (IOM) provided a review of the benefits of current federal laws that offer incentives for or require drug and biologic developers to conduct pediatric studies. The report also highlighted several areas where...
This coming weekend is Indy’s Super Cure, and I am going to be a donor. In my opinion, this is one of the most exciting things about the Super Bowl coming to Indianapolis. Yes, of course, the infectious fan spirit that is filling our streets and buildings, the...
